Cargando…
Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival()
Evolutionary Action analyses of The Cancer Gene Atlas data sets show that many specific p53 missense and gain-of-function mutations are selectively overrepresented and functional in high-grade serous ovarian cancer (HGSC). As homozygous alleles, p53 mutants are differentially associated with specifi...
Autores principales: | Mullany, Lisa K., Wong, Kwong-Kwok, Marciano, David C., Katsonis, Panagiotis, King-Crane, Erin R., Ren, Yi Athena, Lichtarge, Olivier, Richards, JoAnne S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656807/ https://www.ncbi.nlm.nih.gov/pubmed/26585234 http://dx.doi.org/10.1016/j.neo.2015.10.003 |
Ejemplares similares
-
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas
por: Crane, Erin K., et al.
Publicado: (2015) -
Nutlin‐3a selects for cells harbouring TP
53 mutations
por: Kucab, Jill E., et al.
Publicado: (2016) -
The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013) -
Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023) -
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application
por: Pozzo, Federico, et al.
Publicado: (2013)